In contrast, treatment with GPER agonist (G-1) caused a significant decrement in cardiac level of MDA (OVX+T2D+G-1 vs. OVX+T2D+Veh, P ≤ 0.05). This evidence concerns the gene GPER1 and type 2 diabetes mellitus.